 |
인쇄하기
취소
|
EC approves Velcade for multiple myeloma treatment
The European Commission issued on April 27 a positive decision for Velcade (bortezomib) injection, a new treatment for multiple myeloma, a form of blood cancer.
A single license has been granted to market Velcade in the 15 member states of the EU, plus Norway and Iceland. In addition it will be available in the 10 accession countries.
After its approval from the Korea Food and Drug Admin...
A single license has been granted to market Velcade in the 15 member states of the EU, plus Norway and Iceland. In addition it will be available in the 10 accession countries.
After its approval from the Korea Food and Drug Admin...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.